Consumer Court Directs Amazon, Seller to Pay Rs.4.68 Lakh to Customer as Compensation || MP HC: Pension is a Proprietary Right and Cannot be Withheld unless Grave Misconduct is Proved || HP High Court: ITBP Constable Removal For Affair Disproportionate; Orders Compulsory Retirement || Calcutta High Court: Trade Licence Not Required For Advocates’ Partnership Registration || Supreme Court: Courts Cannot Compel Plaintiffs to Accept Compensation Instead of Injunctions || Delhi HC: Saying “Maro Sale Ko” During a Fight Alone Does Not by Itself Establish Intent to Kill || Delhi HC Ordered Removal of Fake News About Judges’ London Badminton Event, Restrained its Sharing || Bombay HC: Calling Police over Routine Transfers or External Complaints is Misconduct || Delhi HC Upheld EC’s Decision Banning Political Ads in the Delhi Metro During Model Code of Conduct || Delhi HC: In the Telegram Case Entire Social Media Platforms Can Be Blocked U/S 69A of the IT Act

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :